An investigational drug (Favipiravir) study for patients who have been hospitalized with the coronavirus COVID-19.
This study will compare the use of the investigational study drug (Favipiravir) with standard treatment vs standard treatment alone.
What we're hoping for
We are hoping to determine if the experimental drug is safe for use and helps people hospitalized with the COVID-19 coronavirus recover.
ClinicalTrials.gov Identifier: NCT04358549